Other drugs, such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and Vericiguat, a soluble guanylate cyclase stimulator, have recently joined the arsenal of HF therapy. Here, SLC5A2 is linked to hydrops fetalis.